On-Body Infusor System for Repatha to Be Discontinued Soon
The Repatha Pushtronix System will be discontinued as of June 30, 2024.
The Repatha Pushtronix System will be discontinued as of June 30, 2024.
Panelists compare the currently available RSV vaccines for adults, considering their target populations, dosing, and administration to prevent RSV infection.
Continue your point-of-care ultrasound learning and become more proficient in practice with this live, virtual course. Learn about POCUS training today.
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lack…
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture…
Pharmacists can help patients distinguish between food allergies and intolerances, as well as facilitate access to life-saving medications and preventative care.
Yu et al. show that Ralstonia, a soil-borne bacterial pathogen, secretes an effector protein inside plant cells to disrupt cellulose biosynthesis and promote the formation of…
Each Ingrezza Sprinkle capsule contains oral granules consisting of valbenazine, a vesicular monoamine transporter 2 inhibitor.
The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for…
Request to CMS is prompted by unexpected spike in catheter prices from some suppliers